Find it in seconds.
Sectors Tags Blog
WMT
37 filings
Timeline Columns Start Research 8-K Categories
2025
Q4 4 filings
Dec 3
Quarterly Report
10-Q View →
Nov 20
Walmart to Voluntarily Withdraw Listing of Common Stock and Company Notes from NYSE and Transfer Listings to Nasdaq
Listing transfer expected to be completed on December 8, 2025 (NYSE) and December 9, 2025 (Nasdaq)
8-K View →
Nov 14
CEO C. Douglas McMillon Retires, John R. Furner Appointed as President and CEO
January 31, 2026 (McMillon's retirement date)
8-K View →
Oct 22
Controller Appointed
Dwayne Milum appointed SVP & Controller, $600K salary
8-K View →
Q3 5 filings
Sep 22
Executive 10b5-1 Trading Plan
Chief People Officer plans to sell max 148,665 shares starting Jan 2026
8-K View →
Sep 19
Executive 10b5-1 Trading Plan
Daniel Danker to sell max 109,976 shares via automated plan
8-K View →
Sep 5
CFO 10b5-1 Trading Plan
CFO Rainey to sell 40,000 shares in Feb-Mar 2026
8-K View →
Aug 29
Q2 2025 Results
Rev $177.4B (+4.8% YoY), EPS $0.88 (+57% YoY)
10-Q View →
Aug 21
Q2 Earnings
Results for three and six months ended July 31, 2025
8-K View →
Q2 6 filings
Jun 6
Q1 2025 Results
Rev $165.6B (+2.5% YoY), EPS $0.56 (-11.1% YoY)
10-Q View →
Jun 6
Annual Shareholder Meeting
91.36% turnout, all 12 directors elected, 7 shareholder proposals rejected
8-K View →
May 15
Q1 Earnings + HQ Relocation
Q1 2025 results for quarter ended April 30, HQ moved to 1 Customer Drive
8-K View →
Apr 28
Debt Offering
$4B notes issued: Floating rate 2027, 4.1% 2027, 4.35% 2030, 4.9% 2035
8-K View →
Apr 24
2025 Proxy Statement
CEO comp: 82% performance-based, Dividend: +13% to $0.94/share
DEF 14A View →
Apr 9
Investment Community Meetings
Press release issued for investor meetings
8-K View →
Q1 4 filings
Mar 17
CEO 10b5-1 Trading Plan
McMillon to sell 233,000 shares Jun 2025-May 2026
8-K View →
Mar 17
John Furner 10b5-1 Trading Plan
157,500 shares max sale over 12 months
8-K View →
Mar 14
FY2025 2025 Results
Unable to extract specific revenue and EPS figures from provided XBRL data format
📌 Filing date of March 14, 2025 for fiscal year ending January 31, 2025
10-K View →
Feb 20
Q4 FY2025 Earnings
Results for Q4 and fiscal year ended January 31, 2025
8-K View →
2024
Q4 4 filings
Dec 6
Q3 2024 Results
Financial data not available in provided content
10-Q View →
Nov 22
Executive 10b5-1 Trading Plan
Kathryn McLay to sell 40,000 shares over 10 months
8-K View →
Nov 19
Q3 Earnings
Results for three and nine months ended October 31, 2024
8-K View →
Oct 18
Opioid Derivative Lawsuit Settlement
$123M insurance payout to settle opioid-related shareholder derivative claims
8-K View →
Q3 4 filings
Sep 6
CFO 10b5-1 Trading Plan
CFO Rainey to sell max 95,800 shares through Dec 2025
8-K View →
Aug 30
Q2 2024 Results
Rev $169.3B (+4.8% YoY), EPS $0.56 (-42.9% YoY)
10-Q View →
Aug 15
Director Appointed
Robert E. Moritz Jr. appointed to Board
8-K View →
Aug 15
Q2 2024 Earnings
Results for three and six months ended July 31, 2024
8-K View →
Q2 4 filings
Jun 7
Annual Shareholder Meeting
91% attendance, all 11 directors elected, executive comp approved
8-K View →
Jun 7
Q1 2024 Results
Rev $161.5B (+6.0% YoY), EPS $0.63 (+200% YoY)
10-Q View →
May 16
Q1 2024 Earnings
Results for three months ended April 30, 2024
8-K View →
Apr 25
2024 Proxy Statement
CEO comp: >80% performance-based, Stock split: 3-for-1
DEF 14A View →
Q1 6 filings
Mar 28
Current Report
8-K View →
Mar 15
Annual Report
10-K View →
Feb 28
Current Report
8-K View →
Feb 23
Current Report
8-K View →
Feb 20
Current Report
8-K View →
Jan 31
Current Report
8-K View →
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.